SEP 24, 2014 11:45 AM PDT

The Business of Biotech

  • Mandy Jackson, US West Coast Editor, SCRIP Intelligence Matthew Herper, Senior Editor, Forbes Luke Timmerman, National Biotechnology
      Mandy Jackson is the US West Coast Editor for Scrip Intelligence. Her focus is US biotech and pharma, including financial, deal making and clinical trials news. Mandy has been a business news reporter for 15 years, covering biotech and pharma companies, biotech law and commercial real estate. She is based in San Diego, California.

      Luke is an award-winning journalist specializing in life sciences. He has served as national biotechnology editor for Xconomy and national biotechnology reporter for Bloomberg News. Luke got started covering life sciences at The Seattle Times, where he was the lead reporter on an investigation of doctors who leaked confidential information about clinical trials to investors. The story won the Scripps Howard National Journalism Award and several other national prizes. Luke holds a bachelor's degree in journalism from the University of Wisconsin-Madison, and during the 2005-2006 academic year, he was a Knight Science Journalism Fellow at MIT.

    A panel of veteran biotech reporters will discuss hot topics in drug development. Expect a lively debate on emerging technologies, shifting dynamics on drug pricing, and the general health of the industry.

    Show Resources
    Loading Comments...